AbbVie posts updates on three early-stage trials: obesity, drug interaction, glabellar linesNov 6Weekly roundup, 5 itemsABBV-295AbbVieUpdated
AbbVie's AGN-151586 Phase 2 forehead lines study completes enrollment; four more trials registeredOct 8Weekly roundup, 5 itemsAbbVieAGN-151586Updated
AbbVie posts Crohn's OLE results; registers Phase 3 lung cancer and Phase 1 glabellar lines trialsAug 13Weekly roundup, 3 itemsABBV-1480AbbVie
AbbVie week: BOTOX oral pain results post; new CLL, myeloma, ABBV-859 trials filedJul 31Weekly roundup, 6 itemsABBV-859AbbVie